Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 6 announcements

Share price: ₹136.40
Market cap: ₹51.03 Cr
Revenue (annual): ₹12.11 Cr
Net profit (annual): ₹-4.16 Cr
P/E (TTM): -42.7×Sector 50.4×
Promoter holding: 64.66%+33.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Capital Structure Change 2 Other Announcement 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

14 Aug 2026 20:22 IST BSE

Financial Results

Parmax Pharma Q1 FY27 Results: Turns Profitable, Net Profit ₹2.2 Cr

Parmax Pharma Ltd reported revenue from operations of ₹8.2 Cr (+331.6% YoY) and net profit of ₹2.2 Cr for Q1 FY27.

Key figure: Net profit ₹2.2 Cr

Open full results → Read the filing ↗

3 Jun 2026 18:45 IST BSE

Financial Results

Parmax Pharma Q4 FY26 Results: Net Loss of ₹0.6 Cr, Loss Narrows

Parmax Pharma Ltd reported revenue from operations of ₹3.3 Cr (-31.2% YoY) and a net loss of ₹0.6 Cr for Q4 FY26.

Key figure: Net loss ₹0.6 Cr

Open full results → Read the filing ↗